라파푸신 유도체 화합물 및 이의 사용 방법

본 개시내용은 천연 산물 FK506 및 라파마이신의 이뮤노필린 리간드 패밀리에 의해 영감을 받은 거대고리 화합물을 제공한다. FK506 및 라파마이신 결합 도메인을 함유한 거대고리의 라파푸신 라이브러리의 생성은 질환을 치료하기 위해 사용되는 약물을 개발하기 위한 새로운 단서로서 큰 가능성을 가질 것이다. The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and ra...

Full description

Saved in:
Bibliographic Details
Main Authors SCHMITT JENNIFER C, YAMAMOTO KANA, KUMAR PUNEET, LIU JUN, HONG SAM, ULLMAN BRETT R, SEMPLE JOSEPH E, SADAGOPAN MAGESH
Format Patent
LanguageKorean
Published 21.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 본 개시내용은 천연 산물 FK506 및 라파마이신의 이뮤노필린 리간드 패밀리에 의해 영감을 받은 거대고리 화합물을 제공한다. FK506 및 라파마이신 결합 도메인을 함유한 거대고리의 라파푸신 라이브러리의 생성은 질환을 치료하기 위해 사용되는 약물을 개발하기 위한 새로운 단서로서 큰 가능성을 가질 것이다. The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and rapamycin. The generation of a Rapafucin library of macrocyles that contain FK506 and rapamycin binding domains should have great potential as new leads for developing drugs to be used for treating diseases.
AbstractList 본 개시내용은 천연 산물 FK506 및 라파마이신의 이뮤노필린 리간드 패밀리에 의해 영감을 받은 거대고리 화합물을 제공한다. FK506 및 라파마이신 결합 도메인을 함유한 거대고리의 라파푸신 라이브러리의 생성은 질환을 치료하기 위해 사용되는 약물을 개발하기 위한 새로운 단서로서 큰 가능성을 가질 것이다. The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and rapamycin. The generation of a Rapafucin library of macrocyles that contain FK506 and rapamycin binding domains should have great potential as new leads for developing drugs to be used for treating diseases.
Author LIU JUN
SADAGOPAN MAGESH
KUMAR PUNEET
YAMAMOTO KANA
SEMPLE JOSEPH E
SCHMITT JENNIFER C
HONG SAM
ULLMAN BRETT R
Author_xml – fullname: SCHMITT JENNIFER C
– fullname: YAMAMOTO KANA
– fullname: KUMAR PUNEET
– fullname: LIU JUN
– fullname: HONG SAM
– fullname: ULLMAN BRETT R
– fullname: SEMPLE JOSEPH E
– fullname: SADAGOPAN MAGESH
BookMark eNrjYmDJy89L5WSwfD13z9uenrcTd7zpXqDwZs6C1_0tbzZtUXg7c8rbqStfr9mj8HpDv8KbuVvezJ2h8KZpzZtZK4EiK19vmsrDwJqWmFOcyguluRmU3VxDnD10Uwvy41OLCxKTU_NSS-K9g4wMjIwMDCxMDMxNHI2JUwUAuCZBYQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20220084074A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20220084074A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:19:07 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20220084074A3
Notes Application Number: KR20227014677
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220621&DB=EPODOC&CC=KR&NR=20220084074A
ParticipantIDs epo_espacenet_KR20220084074A
PublicationCentury 2000
PublicationDate 20220621
PublicationDateYYYYMMDD 2022-06-21
PublicationDate_xml – month: 06
  year: 2022
  text: 20220621
  day: 21
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies THE JOHNS HOPKINS UNIVERSITY
RAPAFUSYN RESEARCH AND DEVELOPMENT, INC
RelatedCompanies_xml – name: THE JOHNS HOPKINS UNIVERSITY
– name: RAPAFUSYN RESEARCH AND DEVELOPMENT, INC
Score 3.3825657
Snippet 본 개시내용은 천연 산물 FK506 및 라파마이신의 이뮤노필린 리간드 패밀리에 의해 영감을 받은 거대고리 화합물을 제공한다. FK506 및 라파마이신 결합 도메인을 함유한 거대고리의 라파푸신 라이브러리의 생성은 질환을 치료하기 위해 사용되는 약물을 개발하기 위한 새로운 단서로서 큰...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 라파푸신 유도체 화합물 및 이의 사용 방법
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220621&DB=EPODOC&locale=&CC=KR&NR=20220084074A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUg1A9V8abpGZompuiZpBqa6iWmpJrpJSclmlslmpmlGqeAFsn5mHqEmXhGmEUwMObC9MOBzQsvBhyMCc1QyML-XgMvrAsQglgt4bWWxflImUCjf3i3E1kUN2js2MjIwMzJUc3GydQ3wd_F3VnN2tvUOUvMLgsgZAHsz5iaOzAyswIa0BWgBoGuYE2hfSgFypeImyMAWADQvr0SIgSk7X5iB0xl295owA4cvdMobyITmvmIRBsvXc_e87el5O3HHm-4FCm_mLHjd3_Jm0xaFtzOnvJ268vWaPQqvN_QrvJm75c3cGQpvmta8mbUSKLLy9aapogzKbq4hzh66QDfEw70c7x2E7GBjMQaWvPy8VAkGhbRUYB_NPC3NOBnYkUk2TwW2bszN0syN00xTTZMSkwwkGWTwmSSFX1qagQvEBS2FMjKUYWApKSpNlQVWuiVJcuCwAgA8uJXU
link.rule.ids 230,309,786,891,25585,76894
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUg1A9V8abpGZompuiZpBqa6iWmpJrpJSclmlslmpmlGqeAFsn5mHqEmXhGmEUwMObC9MOBzQsvBhyMCc1QyML-XgMvrAsQglgt4bWWxflImUCjf3i3E1kUN2js2MjIwMzJUc3GydQ3wd_F3VnN2tvUOUvMLgsgZAHsz5iaOzAyswEa2JeikfdcwJ9C-lALkSsVNkIEtAGheXokQA1N2vjADpzPs7jVhBg5f6JQ3kAnNfcUiDJav5-5529PzduKON90LFN7MWfC6v-XNpi0Kb2dOeTt15es1exReb-hXeDN3y5u5MxTeNK15M2slUGTl601TRRmU3VxDnD10gW6Ih3s53jsI2cHGYgwsefl5qRIMCmmpwD6aeVqacTKwI5Nsngps3ZibpZkbp5mmmiYlJhlIMsjgM0kKv7Q8A6dHiK9PvI-nn7c0AxdICrQsyshQhoGlpKg0VRZYAZckyYHDDQBvOJjH
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%EB%9D%BC%ED%8C%8C%ED%91%B8%EC%8B%A0+%EC%9C%A0%EB%8F%84%EC%B2%B4+%ED%99%94%ED%95%A9%EB%AC%BC+%EB%B0%8F+%EC%9D%B4%EC%9D%98+%EC%82%AC%EC%9A%A9+%EB%B0%A9%EB%B2%95&rft.inventor=SCHMITT+JENNIFER+C&rft.inventor=YAMAMOTO+KANA&rft.inventor=KUMAR+PUNEET&rft.inventor=LIU+JUN&rft.inventor=HONG+SAM&rft.inventor=ULLMAN+BRETT+R&rft.inventor=SEMPLE+JOSEPH+E&rft.inventor=SADAGOPAN+MAGESH&rft.date=2022-06-21&rft.externalDBID=A&rft.externalDocID=KR20220084074A